Forehead Filler: Which Layer Does It Go In, and Why?

Forehead Filler: Which Layer Does It Go In, and Why?

Jangju Kim25 min readEditorial policy

Key takeaways

  • The short answer: studies describe a deep layer under the muscle and a shallow layer under the skin, and artery depth is a key safety reason the choice matters.
  • Why depth matters: a meta-analysis found the artery above the inner brow sits about 3.5 mm deep on average there, and it gets shallower as it rises.
  • Why the forehead is watched closely: in published cases of vision loss after filler, the forehead was the second most common site, though the review calls this a rare complication.
  • Before you book: the US FDA lists forehead injection among filler uses it has not approved, so ask how the layer is chosen and checked.

Forehead filler studies mainly describe two layers, a deep layer under the forehead muscle near the bone and a shallow layer just under the skin, and how deep the forehead arteries run at each spot is a key safety reason the layer matters. The type of forehead dip and the product also guide the plan, but this article explains forehead filler by one thing: how the injection layer relates to the depth of the arteries.

Which Layers Do Forehead Filler Studies Describe?

Which Layers Do Forehead Filler Studies Describe?Which Layers Do Forehead Filler Studies Describe?

An expert technique paper on the forehead says that Proper diagnosis of forehead depressions-categorized as central, bilateral, mixed, or total types-guides targeted treatment strategies using submuscular or subdermal injection planes. Submuscular means under the forehead muscle, close to the bone. Subdermal means just under the skin.

The same paper leans toward the deep layer: Submuscular injections provide structural support, minimizing risks associated with superficial placement, such as uneven distribution and vascular complications. It is rated as expert opinion, the lowest level of evidence, so read it as one group's method rather than a rule.

A general review of filler complications, not specific to the forehead, points the same way: Administering fillers in regions with reduced vascular density, such as the supraperiosteal plane, substantially diminishes the risk of arterial penetration. The supraperiosteal plane is the layer sitting right on the bone. Lower risk is not the same as no risk, and no layer removes the need to know where the arteries are.

Where the Forehead Arteries Run, and How Deep

Where the Forehead Arteries Run, and How DeepWhere the Forehead Arteries Run, and How Deep

Two arteries come up over the brow into the forehead: the supratrochlear artery above the inner brow and the supraorbital artery a little further out. A meta-analysis pooled five studies covering 201 SOA arteries and 282 STA arteries; SOA is the supraorbital artery and STA the supratrochlear artery. Above the eyebrow, it reported 3.53 mm, 95% CI (3.21-3.85) for STA above the eyebrow and 5.53 mm, 95% CI (4.79-6.28) for SOA above the eyebrow. The 95% CI is the range where the true average most likely sits.

Depth changes along the way. The authors found that The supratrochlear artery tends to become more superficial along its path, while the supraorbital artery remains at a consistent depth across various anatomical levels. So a depth that stays clear of the artery just above the brow may not stay clear higher up the forehead, and the inner and outer parts of the forehead are not the same.

From those numbers the authors suggested that For injections in the medial part of the forehead, it is advisable to place the needle up to 2.5 mm deep or laterally to the artery's path, and that injections in the lateral part of the forehead can be administered slightly deeper, up to 3.5 mm. In other words, for the inner forehead these authors suggest staying shallower than the artery or to its side, a different route from the deep layer above. These are averages from pooled studies for injectors planning a procedure, not depths a patient can check, and one person's arteries can sit differently, which is why the same authors recommend an ultrasound scan before injecting.

ArteryWhere measuredAverage depth (95% CI)What the authors noted
Supratrochlear (inner brow)Lower, at the level of the glabella4.45 mm (3.43 to 5.47)Gets shallower as it rises
Supratrochlear (inner brow)Higher, above the eyebrow3.53 mm (3.21 to 3.85)Gets shallower as it rises
Supraorbital (further out)Lower, at the level of the glabella5.68 mm (4.58 to 6.78)Stays at a similar depth
Supraorbital (further out)Higher, above the eyebrow5.53 mm (4.79 to 6.28)Stays at a similar depth

Source: one meta-analysis of five studies. These are averages, not measurements of any one person, and not STON Clinic data.

Where the Forehead Arteries Run, and How DeepWhere the Forehead Arteries Run, and How Deep

This drawing is simplified to show the layers and the general path of one artery. Real arteries vary from person to person.

Why Forehead Arteries Get So Much Attention

Why Forehead Arteries Get So Much AttentionWhy Forehead Arteries Get So Much Attention

Forehead arteries connect to the artery that feeds the eye. A review explains that The injection pressure can cause the fillers to travel retrograde within these vessels, potentially occluding the central retinal artery that supplies the optic nerve and eye, leading to blindness. Retrograde means backward, against the blood flow. It adds that Areas such as the eyebrows, forehead, and nasal regions are particularly susceptible to complications given their dense vascularization by branches of the ophthalmic artery.

A review of published case reports counted 365 new cases of partial or complete vision loss after filler injection and found that The sites that were highest risk were the nose (40.6%), forehead (27.7%), and glabella (19.0%). These are shares of reported cases, not how often it happens per treatment, and the same authors write that blindness and stroke from fillers is a rare complication.

Mapping the Arteries Before Injecting

Mapping the Arteries Before InjectingMapping the Arteries Before Injecting

Because arteries vary, some practitioners look first. The meta-analysis recommends performing a high-resolution linear ultrasonography (USG) exam prior to injection. In a Korean study of 34 patients who had forehead filler with Doppler ultrasound mapping first, Using Doppler ultrasound, the authors successfully traced all 3 blood vessels (supraorbital, supratrochlear, and frontal branch of the superficial temporal arteries) and avoided them during HA injection, and None of the patients experienced arterial complications.

That study had no comparison group and was small, so it shows the mapping was workable rather than proving how much it lowers risk. These are study results, not results from STON Clinic.

How the Needle or Cannula Angle Changes Where Filler Lands

How the Needle or Cannula Angle Changes Where Filler LandsHow the Needle or Cannula Angle Changes Where Filler Lands

Reaching the planned layer depends on the tool and its angle. In a study on four fresh frozen cadaver specimens, where hyaluronic acid was injected into the forehead and checked with ultrasound, Both the cannula technique and the needle technique with the bevel down at a 45-degree angle consistently delivered the filler to the supraperiosteal layer in every case checked, without spreading. A cannula is a thin tube with a blunt tip.

The straight-down approach behaved differently: the 90-degree needle technique, despite correct placement on the periosteum, resulted in filler dispersion across multiple layers. Periosteum is the thin layer covering the bone. This was a small study in specimens, not in living patients, so it tells you placement can vary with technique, not which method a clinic should use for you.

How the Needle or Cannula Angle Changes Where Filler LandsHow the Needle or Cannula Angle Changes Where Filler Lands

Is Forehead Filler an Approved Use?

Approval differs by country, and in the United States the answer is no. Among uses the FDA recommends against, it lists Inject the glabella (area between eyebrows), nose, periorbital area (around the eyes), forehead, or neck, and states: These uses for dermal fillers are not approved by the FDA. It also notes that The risks associated with unapproved uses of dermal fillers, or with the use of unapproved products are not known.

The FDA's patient advice is to Ask your health care provider about their training and experience injecting dermal fillers in the face and hands. For the forehead, that conversation can include which layer is planned and how the arteries will be located.

Signs That Need Care Right Away

The FDA calls unintentional injection into a blood vessel the most concerning risk of dermal fillers, with reported complications that include necrosis (death of tissue), vision abnormalities including blindness, and stroke. Its advice is to Seek immediate medical attention if you experience unusual pain, vision changes, a white, gray, or blue appearance of skin near the injection site, or any signs of a stroke.

Vision changes after a forehead injection need emergency care at once, wherever you are, without waiting to see if they pass.

Questions to Ask at the Consultation

  • Which layer is planned for my forehead, and why that one?
  • How will the arteries be located before injecting?
  • Will a needle or a cannula be used?
  • Can the product be dissolved if needed?
  • What should I do if I notice pain, skin color change or vision change after I leave?

STON Clinic's Volume Treatment Pages

STON Clinic's volume treatment page says which product to use and how deep it goes are decided by the medical team during the consultation. Its Juvéderm page notes that hyaluronic acid filler can be dissolved with a hyaluronidase injection, and asks you to tell the clinic in advance what was placed in the same spot before, whether filler has been dissolved, the medications and supplements you take, and dates coming up. You'll find STON Clinic in Myeongdong, on the 9th floor of Lotte Hotel Seoul's Main Tower, near Euljiro 1(il)-ga Station on Line 2.

Ask a question

References

  1. Proper diagnosis of forehead depressions-categorized as central, bilateral, mixed, or total types-guides targeted treatment strategies using submuscular or subdermal injection planes — PubMed Central
  2. Administering fillers in regions with reduced vascular density, such as the supraperiosteal plane, substantially diminishes the risk of arterial penetration — PubMed Central
  3. 201 SOA arteries and 282 STA arteries — PubMed Central
  4. 365 new cases of partial or complete vision loss after filler injection — PubMed Central
  5. Using Doppler ultrasound, the authors successfully traced all 3 blood vessels (supraorbital, supratrochlear, and frontal branch of the superficial temporal arteries) and avoided them during HA injection — PubMed Central
  6. Both the cannula technique and the needle technique with the bevel down at a 45-degree angle consistently delivered the filler to the supraperiosteal layer — PubMed Central
  7. Inject the glabella (area between eyebrows), nose, periorbital area (around the eyes), forehead, or neck — U.S. Food and Drug Administration

Frequently asked questions

Q. Which layer does forehead filler go in, and why?

A. Studies mainly describe two layers: a deep layer under the forehead muscle near the bone, and a shallow layer just under the skin. The type of forehead dip helps decide which is used, and how deep the forehead arteries run at each spot, which varies by person and by height on the forehead, is a key safety reason the layer matters.

Q. How deep are the forehead arteries?

A. In one meta-analysis, the supratrochlear artery above the inner brow averaged 3.53 mm deep above the eyebrow, and the supraorbital artery averaged 5.53 mm there. The supratrochlear artery gets shallower as it rises. These are averages from studies, not STON Clinic data.

Q. Is forehead filler dangerous?

A. The most serious risk is filler entering an artery, which can lead to tissue damage, vision loss or stroke. In a review of 365 published vision loss cases, the forehead was involved in 27.7% of the cases, second after the nose, and the authors still describe this as rare. Knowing where the arteries run and which layer is used is part of lowering that risk.

Q. Is forehead filler FDA approved?

A. No. The US FDA lists forehead injection among uses of dermal fillers it has not approved, and says the risks of unapproved uses are not known. Approval rules differ by country.

Q. What signs after forehead filler need urgent care?

A. The FDA advises seeking immediate medical attention for unusual pain, vision changes, a white, gray or blue look to the skin near the injection site, or any signs of a stroke.

Jangju Kim

Jangju Kim Senior Director

JANGJU KIM

Dr. Jangju Kim is a clinic director at STON Clinic, LOTTE HOTEL in Myeongdong.

Career / Education

  • Current) Director of STON Clinic, LOTTE HOTEL Myeongdong
  • Graduated from Kyung Hee University College of Medicine
View profile

Comments